Comparative effectiveness and resource utilization of nab-paclitaxel plus gemcitabine vs FOLFIRINOX or gemcitabine for the first-line treatment of metastatic pancreatic adenocarcin...

por Braiteh, Fadi, Patel, Manish B, Parisi, Monika, Ni, Quanhong, Park, Siyeon, Faria, Claudio
Publicado 2017

Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis

por Mahtani, Reshma L, Parisi, Monika, Glück, Stefan, Ni, Quanhong, Park, Siyeon, Pelletier, Corey, Faria, Claudio, Braiteh, Fadi
Publicado 2018